Is Novartis India Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Novartis India Ltd (500672.BO) is currently classified as NOT HALAL as of December 2025. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Novartis India Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Novartis India Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Novartis India Ltd?

Muslim investors may consider investing in Novartis India Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Novartis India Ltd classified as NOT HALAL?

Musaffa determines the Shariah status of Novartis India Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Novartis India Ltd updated?

The Shariah compliance status of Novartis India Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Novartis India Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Novartis India Ltd?

You can check the latest Shariah compliance status of Novartis India Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Novartis India Ltd 500672.BO

₹1,208.80 ₹12.10 (0.99%) 1D

Last Updated: May 15, 12:00 AM·BSE

500672.BO Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: December 22, 2025

Report Source: 2026 2nd Quarter Report

Novartis India Ltd. Stock Analysis 500672.BO

India Health Care Micro Cap Report: Q2, 2026

Novartis India Ltd. engages in developing and marketing transformative treatments for people in areas of medical need. The company is headquartered in Mumbai, Maharashtra and currently employs 56 full-time employees. The firm is primarily engaged in the business of trading of Pharmaceuticals. The company operates in the Pharmaceutical business segment. The Company’s brands hold key positions in therapeutic areas, such as, Voveran, which is the brand for bone and pain; Simulect, Certican, Sandimmun, Neoral, and Myfortic, which is the brand for transplantation immunology; and Tegrital and Exelon, which is the brand for neurosciences.

Key Statistics of Novartis India Ltd (500672.BO)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

₹1,200.00₹1,228.40

Today's Open

₹1,220.90

Volume

1777.00

P/E Ratio (TTM)

31.01

52 Week Range

₹750.00₹1,275.00

Market Cap

25.07B

Avg. Volume

7261.59

Dividend Yield

1.97%

Financial Metrics & Statements of Novartis India Ltd (500672.BO)

FAQ's for Novartis India Ltd (500672.BO)

According to Musaffa’s Shariah screening methodology, Novartis India Ltd (500672.BO) is currently classified as NOT HALAL as of December 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.